Regeneron is a clinical research site located in Tarrytown, New York, United States 10591.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Regeneron has participated in 1 clinical trials.
Therapeutic areas: Fibrodysplasia Ossificans Progressiva (FOP).
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Regeneron has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Regeneron has 1 clinical trials on record. Their work covers Fibrodysplasia Ossificans Progressiva (FOP).
Regeneron has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.